Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote & Recent News Algernon Pharmaceuticals Inc. C.AGN

Alternate Symbol(s):  AGNPF

Algernon Pharmaceuticals is a clinical stage drug development company focused on the disease areas of stroke, idiopathic pulmonary fibrosis (IPF) & chronic cough. The company's business model is highly capital efficient and strives to deliver maximum shareholder value. Algernon's unique approach to drug discovery is based on the concept of drug repurposing.

The Power Play by The Market Herald
{{currentVideo.videoCaption}}
< Previous Video {{moreVideoText}} Next Video >

Stock Price Chart (CSE:AGN)

Fundamentals Snapshot (CSE:AGN)

Bullboard Posts (CSE:AGN)

Article on AGN

Came across this article on the potential for DMT to become a breakthrough treatment for people who suffer a stroke. It also touches on...
SkywalkerofLuke - 2 days ago

Did I miss a news release?

Why is this dropping this time.
GoodLife60 - 2 days ago

Video with CEO

Found this video of the AGN.c AGNPF CEO featured on Market One discussing their investigation into DMT as a treatment for strokes...
SkywalkerofLuke - 3 days ago

AGN Begins Screening for Phase 1 Study

AGN.c AGNPF announced last week they began screening subjects for its Phase 1 clinical study of an intravenous formulation of AP-188...
SkywalkerofLuke - 4 days ago

Expecting AGN.c to reach phase 2 of DMT trials swiftly.

Expecting AGN.c to reach phase 2 of DMT trials swiftly.    AGN.c has started screening  subjects for its phase 1...
stockpatrol - 5 days ago

AGN.c starting to stabilize in the high $2 range.

AGN.c starting to stabilize in the high $2 range.    https://twitter.com/StckMasterFlash/status/1592966259284799488...
stockpatrol - 6 days ago

follow C.AGN on

PIPELINE TARGETED DISEASES MEDIA MANAGEMENT

VIDEO

Video Q&A With CEO Christopher J. Moreau


Download the latest Investor Presentaion
Download the latest Investor Presentation

Visit the company website


Algernon Pharmaceuticals | The Power Play
{{currentVideo.videoCaption}}
< Previous Video {{moreVideoText}} Next Video >

Download the Presentaion

TWITTER


FACEBOOK